These results suggest that Gal-9 attenuates disease severity in MRL/lpr lupus-prone mice, at least partly, by regulating Tim-3 expressing effector Th1, Th17, and activated CD8 T cells. This evidence concerns the gene LGALS9 and systemic lupus erythematosus.